Barriers to access for Canadians who use cannabis for therapeutic purposes

International Journal of Drug Policy

Volumn 25, Issue 4, 2014, Pages 691-699

  Belle Isle, Lynne ^a,b   Walsh, Zach ^c   Callaway, Robert ^d   Lucas, Philippe ^b   Capler, Rielle ^e   Kay, Robert ^f   Holtzman, Susan ^c  

^a CANADIAN AIDS SOCIETY   (Canada)

^b UNIVERSITY OF VICTORIA   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d Medical Cannabis Advocate   (Canada)

^e Canadian Association of Medical Cannabis Dispensaries   (Canada)

^f GreenLeaf Technologies   (Canada)

Author keywords

Barriers to access; Canada; Cannabis; Cannabis for therapeutic purposes; Health services analytical framework; Medical cannabis; Regulations

Indexed keywords

MEDICAL CANNABIS;

ACCESS TO INFORMATION; ADULT; ARTICLE; CANADA; DRUG USE; FEMALE; HEALTH CARE QUALITY; HEALTH SERVICE; HEALTH SURVEY; HUMAN; MALE; PHYSICIAN; PRIORITY JOURNAL; QUESTIONNAIRE; ADOLESCENT; CANNABIS SMOKING; COMMUNICATION DISORDER; CROSS-SECTIONAL STUDY; DOCTOR PATIENT RELATION; HEALTH CARE DISPARITY; MIDDLE AGED; SUPPLY AND DISTRIBUTION;

ADOLESCENT; ADULT; CANADA; COMMUNICATION BARRIERS; CROSS-SECTIONAL STUDIES; FEMALE; HEALTHCARE DISPARITIES; HUMANS; MALE; MARIJUANA SMOKING; MEDICAL MARIJUANA; MIDDLE AGED; PHYSICIAN-PATIENT RELATIONS; QUESTIONNAIRES;

EID: 84906061759     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2014.02.009     Document Type: Article

References (25)

1. Canadian Addiction Survey (CAS): A national survey of Canadians' use of alcohol and other drugs: Prevalence of use and related harms: Detailed report 2005, Canadian Centre on Substance Abuse, Ottawa. E.M. Adlaf, P. Begin, E. Sawka (Eds.).
2. Angélico A.P., Crippa J.A.S., Loureiro S.R. Social anxiety disorder and social skills: A critical review of the literature. International Journal of Behavioural Consultation and Therapy 2013, 7(4):16-23.
3. Belle-Isle L. Cannabis as therapy for people living with HIV/AIDS: Our right, our choice 2006, Canadian AIDS Society, Ottawa.
4. Belle-Isle L., Hathaway A. Barriers to access to medical cannabis for Canadians living with HIV/AIDS. AIDS Care 2007, 19(4):500-506.
5. Bottorff J.L., Bissell L.J.L., Balneaves L.G., Oliffe J.L., Capler N.R., Buxton J. Perceptions of cannabis as a stigmatized medicine: A qualitative descriptive study. Harm Reduction Journal 2013, 10(2). Retrieved from http://www.harmreductionjournal.com/content/10/1/2.
6. Bowling A. Just one question: If one question works, why as several?. Journal of Epidemiology and Community Health 2005, 59:342-345.
7. Canadian Association of Medical Cannabis Dispensaries Dispensaries are indispensable: Compassion clubs launch first certification program 2013, Retrieved from http://www.newswire.ca/en/story/1187053/dispensaries-are-indispensable-compassion-clubs-launch-first-certification-program.
8. Canadian Medical Association MD role in use of medical marijuana baffles many doctors: Survey 2012, Retrieved from http://www.cma.ca/md-role-medical-marijuana-baffles.
9. Canadian Medical Association Statement from the Canadian Medical Association on new regulations on medical marijuana 2013, Retrieved from http://www.cma.ca/multimedia/CMA/Content_Images/Inside_cma/Media_Release/2013/Statement_Medical_Marijuana_regulations_en.pdf.
10. Capler N.R. Canadian Compassion Clubs. The pot book: A complete guide to cannabis 2010, 432-440. Park Street Press, Rochester, Vermont. J. Holland (Ed.).
11. Gartlehner G., Hansen R.A., Morgan L.C., Thaler K., Lux L., Van Noord M., et al. Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: An updated meta-analysis. Annals of Internal Medicine 2011, 155(11):772-785. 10.1059/0003-4819-155-11-201112060-00009.
12. Government of Canada Marihuana for medical purposes regulations. Canada Gazette 2012, 146(50). Retrieved from http://gazette.gc.ca/rp-pr/p1/2012/2012-12-15/html/reg4eng.html.
13. Health Canada Marihuana medical access program statistics 2013, Retrieved from http://www.hc-sc.gc.ca/dhp-mps/marihuana/stat/index-eng.php.
14. The pot book: A complete guide to cannabis: Its role in medicine, politics, science, and culture 2010, Park Street Press, Rochester, Vermont. J. Holland (Ed.).
15. Jacobs B., Ir P., Bigdeli M., Annear P.L., Van Damme W. Addressing access barriers to health services: An analytical framework for selecting appropriate interventions in low-income Asian countries. Health Policy and Planning 2012, 27:288-300.
16. Jones C., Hathaway A.D. Marijuana medicine and Canadian physicians: Challenges to meaningful drug policy reform. Contemporary Justice Review: Issues in Criminal, Social, and Restorative Justice 2008, 11(2):165-175.
17. Lucas P. It can't hurt to ask: A patient-centered quality of service assessment of Health Canada's medical cannabis policy and program. Harm Reduction Journal 2012, 9(2). Retrieved from. http://www.harmreductionjournal.com.ezproxy.library.uvic.ca/content/pdf/1477-7517-9-2.pdf.
18. Lucas P. Cannabis as an adjunct to or substitute for opiates in the treatment of chronic pain. Journal of Psychoactive Drugs 2012, 44(2):125-133.
19. Penchansky R., Thomas J.W. The concept of access: Definition and relationship to consumer satisfaction. Medical Care 1981, XIX(2):127-140.
20. Peters D.H., Garg A., Bloom G., Walker D.G., Brieger W.R., Rahman M.H. Poverty and access to health care in developing countries. Annals of the New York Academy of Sciences 2008, 1136:161-171.
21. Shelef A., Mashiah M., Schumacher I., Shine O., Baruch Y. Medical grade cannabis (MGC): Regulation mechanisms, the present situation around the world and in Israel. Harefuah 2011, 150(12):913-917.
22. Tse W.S., Bond A.J. The impact of depression on social skills: A review. Journal of Nervous and Mental Disease 2004, 192:260-268. 10.1097/01.nmd.0000120884.60002.2b.
23. Uzun S., Kozumplik O., Jakovljević M., Sedić B. Side effects of treatment with benzodiazepines. Psychiatria Danubina 2010, 22(1):90-93.
24. Walsh Z., Callaway R., Belle-Isle L., Capler R., Kay R., Lucas P., et al. Cannabis for therapeutic purposes: Patient characteristics, access, and reasons for use. International Journal of Drug Policy 2013, 25(6):511-516.
25. Ward S.E., Goldberg N., Miller-McCauley V., Mueller C., Nolan A., Pawlik-Plank D., et al. Patient-related barriers to management of cancer pain. Pain 1993, 52(3):319-324.